Schroder Investment Management Group Sarepta Therapeutics, Inc. Transaction History
Schroder Investment Management Group
- $94.5 Billion
- Q3 2024
A detailed history of Schroder Investment Management Group transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 3,203 shares of SRPT stock, worth $381,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,203
Previous 37,261
91.4%
Holding current value
$381,605
Previous $5.89 Million
93.21%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
84MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.07 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$746 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$519 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$509 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...